Literature DB >> 27109017

Salvage Extracorporeal Membrane Oxygenation Prior to "Bridge" Transcatheter Aortic Valve Replacement.

Peter Chiu1, William F Fearon2, Lindsay A Raleigh3, Grayson Burdon1, Vidya Rao3, Jack H Boyd1, Alan C Yeung2, David Craig Miller1, Michael P Fischbein1.   

Abstract

We describe a patient who presented in profound cardiogenic shock due to bioprosthetic aortic valve stenosis requiring salvage Extracorporeal Membrane Oxygenation followed by a "bridge" valve-in-valve transcatheter aortic valve replacement. doi: 10.1111/jocs.12750 (J Card Surg 2016;31:403-405).
© 2016 Wiley Periodicals, Inc.

Entities:  

Mesh：

Year:  2016        PMID： 27109017      PMCID： PMC4951207          DOI： 10.1111/jocs.12750

Source DB:  PubMed          Journal:  J Card Surg        ISSN： 0886-0440            Impact factor:   1.620


  6 in total

1.  Survival and long-term outcomes following bioprosthetic vs mechanical aortic valve replacement in patients aged 50 to 69 years.

Authors:  Yuting P Chiang; Joanna Chikwe; Alan J Moskowitz; Shinobu Itagaki; David H Adams; Natalia N Egorova
Journal:  JAMA       Date:  2014-10-01       Impact factor: 56.272

2.  5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial.

Authors:  Samir R Kapadia; Martin B Leon; Raj R Makkar; E Murat Tuzcu; Lars G Svensson; Susheel Kodali; John G Webb; Michael J Mack; Pamela S Douglas; Vinod H Thourani; Vasilis C Babaliaros; Howard C Herrmann; Wilson Y Szeto; Augusto D Pichard; Mathew R Williams; Gregory P Fontana; D Craig Miller; William N Anderson; Jodi J Akin; Michael J Davidson; Craig R Smith
Journal:  Lancet       Date:  2015-03-15       Impact factor: 79.321

3.  Balloon aortic valvuloplasty under temporary mechanical circulatory support as a bridge to aortic valve replacement in a patient with hemodynamic failure secondary to critical aortic valve stenosis.

Authors:  Salil Deo; Kevin L Greason; Rajiv Gulati; Allan S Jaffe; David R Holmes
Journal:  Heart Surg Forum       Date:  2012-06       Impact factor: 0.676

4.  Transcatheter aortic valve implantation in failed bioprosthetic surgical valves.

Authors:  Danny Dvir; John G Webb; Sabine Bleiziffer; Miralem Pasic; Ron Waksman; Susheel Kodali; Marco Barbanti; Azeem Latib; Ulrich Schaefer; Josep Rodés-Cabau; Hendrik Treede; Nicolo Piazza; David Hildick-Smith; Dominique Himbert; Thomas Walther; Christian Hengstenberg; Henrik Nissen; Raffi Bekeredjian; Patrizia Presbitero; Enrico Ferrari; Amit Segev; Arend de Weger; Stephan Windecker; Neil E Moat; Massimo Napodano; Manuel Wilbring; Alfredo G Cerillo; Stephen Brecker; Didier Tchetche; Thierry Lefèvre; Federico De Marco; Claudia Fiorina; Anna Sonia Petronio; Rui C Teles; Luca Testa; Jean-Claude Laborde; Martin B Leon; Ran Kornowski
Journal:  JAMA       Date:  2014-07       Impact factor: 56.272

5.  Emergency and prophylactic use of miniaturized veno-arterial extracorporeal membrane oxygenation in transcatheter aortic valve implantation.

Authors:  Oliver Husser; Andreas Holzamer; Alois Philipp; Julio Nunez; Vicente Bodi; Thomas Müller; Matthias Lubnow; Andreas Luchner; Dirk Lunz; Günter A J Riegger; Christof Schmid; Christian Hengstenberg; Michael Hilker
Journal:  Catheter Cardiovasc Interv       Date:  2013-04-29       Impact factor: 2.692

6.  Transapical aortic valve implantation in patients with poor left ventricular function and cardiogenic shock.

Authors:  Axel Unbehaun; Miralem Pasic; Semih Buz; Stephan Dreysse; Marian Kukucka; Roland Hetzer; Thorsten Drews
Journal:  J Thorac Cardiovasc Surg       Date:  2014-08-09       Impact factor: 5.209
  6 in total
  1 in total

Review 1.  Mechanical circulatory support in patients with severe aortic stenosis and left ventricular dysfunction undergoing percutaneous coronary intervention.

Authors:  Mohamad Alkhouli; Ahmed Al Mustafa; Zakeih Chaker; Fahad Alqahtani; Sami Aljohani; David R Holmes
Journal:  J Card Surg       Date:  2017-03-07       Impact factor: 1.620
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.